Our group previously demonstrated that the RASSF1 gene has a significant tumor suppressor role in cutaneous melanoma. The RASSF8 gene is a member of the N-terminal RASSF gene family. Previously, we identified RASSF8 (HOJ1, NCBI Gene ID:11228) expression in cutaneous melanoma; however the functional role of RASSF8 in melanoma is not known. RASSF8 expression was assessed in melanoma cell lines an...

Cancer vaccines aim at inducing (a) tumor-specific effector T cells able to reduce/eliminate the tumor mass, and (b) long-lasting tumor-specific memory T cells able to control tumor relapse. We have shown earlier, in 18 human histocompatibility leukocyte antigen (HLA)-A*0201 patients with metastatic melanoma, that vaccination with peptide-loaded CD34-dendritic cells (DCs) leads to expansion of ...

Recently, there has been a great interest in melanoma and stromal cell-to-cell interactions behind the progressive behavior of melanoma. By vitro co-culturing using sequential seeding conditions imitating niche properties, gained hybrid variants are visualized by high content fluorescent microscopy. The co-culture experiment applied consecutive order primarily plated HDF-RFP-ZeoR fibroblast mon...

Melanoma is the deadliest form of skin cancer, primarily due to its high metastatic propensity and therapeutic resistance in advanced stages. The frequent inactivation p53 tumour suppressor protein melanomagenesis may predict promising outcomes for activators melanoma therapy. Herein, we aimed investigate antitumor potential p53-activating agent SLMP53-2 against melanoma. Two- three-dimensional...

Starting from studying a melanoma patient with heterogenous response, In article 2100098, Lujun Shen, Ying Wu, and co-workers identified inducible regulatory T cells (iTregs) as key predictor of treatment response PD-1 inhibitor based immunotherapy in melanoma. Further analysis multi-omics data this special public datasets uncover the molecular features potential therapeutic targets iTregs.

Heightened cutaneous immune surveillance in atopic patients may inhibit development of melanoma. The aim of this study was to analyse the association between atopy and melanoma (development and outcome). A total of 188 cases of melanoma and 596 healthy controls were interviewed by telephone with a standardized questionnaire on atopic, demographic and melanoma characteristics. Cases were matched...

utaneous foot melanoma is rare; it accounts for approximately 1% of all cutaneous melanoma and can be challenging to manage [1]. There are four main variants of cutaneous malignant melanomas (CMMs), superficial spreading melanoma (SSM), lentigo malignant melanoma (LMM), nodular melanoma (NM) and acral lentiginous melanoma (ALM). Superficial spreading melanoma accounts for approximately 65% of a...

Acro-lentiginous melanoma, a pigmented lesion of the extremities, especially palms and soles, is defined by malignant tumor proliferation with high metastatic potential, which develops at expense melanocytes. Its incidence constantly increasing varies according to country ethnicity. diagnosis primarily histopathological, its management remains multidisciplinary, where surgery plastic surgeon oc...

Amelanotic melanoma is met only in 28% of cases with malignant melanoma. The incidence of brain metastases in patients with malignant melanoma ranges from 643% of cases. Brain metastases are frequently associated with malignant melanoma after the intratumorale hemorrhage. We choose to present the case of 58-years-old men with a frontal brain metastasis of amelanotic malignant melanoma.

Introduction: Although malignant melanomas (MM) are common in the head and neck region; primary malignant melanoma of the external auditory canal (EAC) is rare.   Case Report: We present the case of a 50-year-old symptomatic man with a malignant melanoma of the external auditory canal, which clinically masqueraded as a haemangioma. The patient subsequently developed extensive loco-regional me...